ALLIANCEBERNSTEIN L.P. - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 113 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$2,016,000
+82.4%
669,770
+48.5%
0.00%
+100.0%
Q1 2015$1,105,000
+3583.3%
451,090
+3788.7%
0.00%
Q4 2014$30,000
-73.2%
11,600
-26.1%
0.00%
Q3 2014$112,000
+111.3%
15,700
+91.5%
0.00%
Q2 2014$53,000
+1225.0%
8,200
+1133.1%
0.00%
Q1 2014$4,000
-95.3%
665
-96.3%
0.00%
Q4 2013$85,000
-26.1%
18,019
-22.1%
0.00%
Q3 2013$115,000
-24.3%
23,119
-20.9%
0.00%
Q2 2013$152,00029,2430.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 1,320,000$9,425,00010.46%
RA Capital Management 4,869,261$34,767,0004.11%
GREAT POINT PARTNERS LLC 400,000$2,856,0001.23%
Healthcare Value Capital, LLC 100,000$714,0000.69%
DSC Advisors, L.P. 175,000$1,250,0000.63%
Quantitative Systematic Strategies LLC 107,416$803,0000.47%
Visium Asset Management, LP 4,093,890$29,230,0000.43%
Rhenman & Partners Asset Management AB 201,171$1,436,0000.42%
EAM Investors, LLC 277,807$1,984,0000.40%
ESSEX INVESTMENT MANAGEMENT CO LLC 354,861$2,534,0000.39%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders